|
|
Article: Wyeth-Ayerst Laboratories Introduces Thin-wall Needle for Bicillin C-R (penicillin G benzathine and penicillin G procaine suspension) Injectable Penicillin
- Article from:
- PR Newswire
- Article date:
- December 11, 1997
CopyrightCOPYRIGHT 1997 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
PHILADELPHIA, Dec. 10 /PRNewswire/ -- Wyeth-Ayerst Laboratories, a division of American Home Products Corporation (NYSE: AHP), announced today that a new thin-wall needle for Bicillin(R) C-R injectable penicillin has received marketing clearance by the U.S. Food and Drug Administration. Bicillin C-R is marketed by Wyeth-Lederle Vaccines and Pediatrics, a division of Wyeth-Ayerst Laboratories.
The new thin-wall needle, designed to help reduce injection site discomfort, is 20 percent shorter than the previous needle used for pediatric patients and has 22 percent less skin surface area penetration.
Bicillin C-R products are indicated for treatment of ...